Indication
For treatment of adults with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Medicine details
- Medicine name:
- tofersen sodium (Qalsody)
- SMC ID:
- SMC3002
- Pharmaceutical company
- Biogen
- BNF chapter
- Central nervous system
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC